Instituto de Microscopía Electrónica y Materiales (IMEYMAT)
Forschungsinstitut
AstraZeneca (United Kingdom)
Cambridge, Reino UnidoPublikationen in Zusammenarbeit mit Forschern von AstraZeneca (United Kingdom) (1)
2022
-
Efficacy and safety of intramuscular administration of tixagevimab–cilgavimab for early outpatient treatment of COVID-19 (TACKLE): a phase 3, randomised, double-blind, placebo-controlled trial
The Lancet Respiratory Medicine, Vol. 10, Núm. 10, pp. 985-996